.
Much effort has therefore been invested in the design of vaccines which can protect high-risk groups from P. aeruginosa infections. One group of potential vaccine candidates is based on polysaccharide components that P. aeruginosa presents to its host (9, 40, 50) . The outer membrane proteins are a second group because there is a limited number of abundant proteins, three of which, porin protein F (OprF), lipoprotein I (OprI), and protein H2 (OprH2), cross-react immunologically between the different serotypes of P. aeruginosa (35) . Furthermore, protection of mice against P. aeruginosa was obtained after administering either a mixture of outer membrane proteins (46) or a purified OprF preparation (18, 29) . Recently the gene encoding porin protein F (OprF) has been cloned and characterized in detail (13, 49) .
In the present study we report the cloning and characterization of the gene coding for P. aeruginosa lipoprotein I (OprI). Its counterpart in Escherichia coli, Braun's lipoprotein, has the probable function of a physical link between the outer membrane and the peptidoglycan layer (16) . Both proteins are small outer membrane proteins containing covalently bound fatty acids (21, 32) , but they differ considerably in their amino acid compositions and their fatty acid contents (32) . Here we show for P. aeruginosa lipoprotein I that the deduced amino acid sequence of 83 amino acid residues (including the leader peptide) differs considerably from the sequence of Braun's lipoprotein. Some important features, however, are identical, like the signal peptidase * Corresponding author. recognition sequence and the two last C-terminal residues, which in E. coli provide the link to the peptidoglycan layer.
The cloning and expression of P. aeruginosa outer membrane lipoprotein I (OprI) in E. coli will be the prerequisite for testing its immunogenic and protective capacities against P. aeruginosa infections.
MATERIALS AND METHODS
Bacterial strains and growth conditions. P. aeruginosa serotype 12 (International Antigenic Typing Scheme; ATCC 33359) was a clinical isolate from the tracheal secretions of a pneumonia patient. P. aeruginosa serotype 6 was obtained from the American Type Culture Collection, Rockville, Md. (ATCC 33354). E. coli NM539 (supF hsdR [P2 cox3]) was used as host (15) for plating of the genomic library, and E. coli JM109 [recAl endAl gyrA96 thi hsdRJ7 supE44 relAl X-A(lac-proAB) (F' traD36 proAB lacIq ZAM15)] (53) was used for subcloning in plasmids. P. aeruginosa and E. coli JM109 were grown in LB broth. Lambda phage was grown on Trypticase agar plates in Trypticase top agarose (BBL Microbiology Systems, Cockeysville, Md.). For large-scale phage preparations, E. coli NM539 cells were grown in NZ medium (27) .
Isolation of monoclonal antibodies. The isolation of monoclonal antibodies has been described recently (28) . Outer membrane proteins were extracted from P. aeruginosa serotype 12 cells by the method of Mizuno and Kageyama (33) and used for immunization of mice.
Monoclonal antibodies were produced by standard methods. One of these monoclonal antibodies, 6A4, was specific for lipoprotein I and was used in this study.
Screening of a genomic library of P. aeruginosa DNA for lipoprotein I sequences. The construction of the P. aeruginosa (serotype 6) genomic library in A EMBL3 phage has been described previously (13) .
Recombinant phage were plated at a density of 400 PFU per 9-cm petri dish. (53) and sequenced with standard M13 primers. One specific oligodeoxynucleotide primer, I1 (see Fig. 1 and below), was constructed in order to complete the sequence of the second strand.
Mapping of the transcription start site. RNA was extracted from P. aeruginosa cells by the hot phenol method (1). For Northern (RNA) blots, RNA was denatured by glyoxal treatment, separated on agarose gels, and blotted as described by Thomas (44) . The 5' end of the lipoprotein I mRNA was mapped by the S1 protection method (47) as described previously for the porin F mRNA (13) . Alternatively, a primer extension reaction using reverse transcriptase was carried out (12) . Either 20 or 40 Fg of total P. aeruginosa RNA was used. cDNA synthesis was primed with the oligodeoxynucleotide I1 (5'-CAGAACAGCAGC CAGAG-3'), which is complementary to the OprI DNA sequence between bases 32 and 48 close to the 5' end of the coding region (see Fig. 1 and 2) and stopped at the 5' end of the RNA. Radioactivity was incorporated into the cDNA by the addition of 10 CTG GCT CTG GCT OCT OTT CTG GCC ACC GGT TGC AGC AGC CAC TCC leu ala leu ala ala val leu ala thr gly cys ser ser his ser 80 100
AAA GAA ACC OLA GCT COT CTG ACC GCT ACC GAA GAC GCA OCT GCT lys glu thr glu ala arg leu thr ala thr glu asp ala ala ala 120 140 160
COT GCT CLG GCT CGC GCT GOC GaA OCC TAT CGC AAG GCT GAC GAa arg ala gln ala arg ala asp glu ala tyr arg lys ala asp glu 180 200
OCT CTG GGC OCT OCT CLG ARA GCT CAG CLG ACC GCT G=C GJU OCT ala leu gly ala ala gln lys ala gln gln thr ala asp glu ala 220 240 ARC GAG COT 0CC CTG COC ATG CTG aAA ARA 0CC AGC COC AAG TAa asn glu arg ala leu arg met leu glu lys ala ser arg lys * Kageyama (33) . Cells (400 ml) were harvested at late log phase by centrifugation at 4,000 x g for 10 min at 4°C, washed once in buffer I (50 mM glucose, 25 mM Tris hydrochloride, 10 mM EDTA, pH 8.0), and suspended in 30 ml of the same buffer. The cells were then broken by two passages through a French press (Aminco, SLM Instruments Inc., Urbana, Ill.). The French press homogenate was centrifuged for 60 min at 100,000 x g and 4°C, and the supernatant was kept as the soluble fraction. The precipitate was suspended in 12 ml of buffer I, 1% (vol/vol) Triton X-100 was added, and the membrane fraction was solubilized by shaking for 60 min at 37°C. Insoluble material was precipitated by 10 min of centrifugation at 12,000 rpm in Eppendorf tubes in a Sigma centrifuge.
The proteins in the soluble and membrane fractions were separated by electrophoresis on 15% polyacrylamide gels (14) . After electrophoresis, proteins were stained with Coomassie blue R250 (Serva, Westbury, N.Y.). Alternatively, for immunoblotting (45) , proteins were electrophoretically transferred to nitrocellulose membranes (Sartorius, Gottingen, Federal Republic of Germany) in a semidry blotting apparatus (Orpegen, Heidelberg, Federal Republic of Germany) (26) . The immunodetection of lipoprotein I bands was done with the 6A4 monoclonal antibodies and an alkaline phosphatase color reaction as described above for the colony screening procedure. 
RESULTS
Mouse monoclonal antibodies to P. aeruginosa outer membrane proteins were raised as described (28 Fig. 1 ). The 3.4-kb fragment was divided into 2.1-and 1.3-kb SalI-PstI pUC19 subclones, the larger of which still reacted positively with the antibody. This fragment could be further divided into a positively reacting SphI-SalI fragment of 0.9 kb and an SphI-PstI fragment of 1.2 kb. Finally, a 625-base-pair TaqI fragment could be subcloned that overlaps the SphI site and contains the whole gene (subclone pITaql).
DNA sequence analysis. From the amino acid composition data of Mizuno and Kageyama (32) it was known that the P. aeruginosa lipoprotein I contains no proline, valine, isoleucine, phenylalanine, or tryptophan. Therefore it was easy to identify potential protein I coding sequences. The 0.9-kb SphI-SalI fragment was sequenced from both sides. The sequence next to the SphI site was devoid of codons for the five amino acids not present in protein I. The open reading frame starts 228 nucleotides away from the SphI site and contains the major N-terminal portion of the protein I gene. Sequence analysis of the adjacent SphI-PstI fragment cloned in pUC19 showed that the seven C-terminal amino acid residues are encoded in this fragment. The complete sequence of the lipoprotein I gene (Fig. 2) is contained in the 625-base-pair TaqI subclone pITaql, both strands of which were sequenced (Fig. 1) . The sequence was assembled from the sequences of several subclones as well as three exonuclease III deletion clones. The last part of the sequence of the second strand was confirmed using the primer extension oligonucleotide I1 (see below and Fig. 1) .
The open reading frame most likely codes for lipoprotein I for the following reasons. The polypeptide encoded is small; the N terminus contains a typical procaryotic signal sequence for transport across the cytoplasmic membrane with a positively charged lysine residue close to the initiator methionine and a central portion of nine hydrophobic amino acid residues (39) . Two lines of evidence indicate that the signal sequence has a length of 19 amino acid residues and that the N-terminal amino acid residue of the mature protein I is the cysteine in position 20. First, the cysteine is contained in the sequence Gly-Cys-Ser-Ser, which is identical in the E. coli lipoprotein, the cysteine being the Nterminal amino acid residue (24) . This residue is also the one modified with glycerol and fatty acid residues in E. coli (21) . In P. aeruginosa the amino acid composition analysis had exhibited a peak, X, which was thought to possibly be glyceryl cysteine (32) ; this would correspond to cysteine also being the N-terminal amino acid in the mature P. aeruginosa lipoprotein. Furthermore, the open reading frame yielded a sequence with a highly nonrandom amino acid composition for the mature protein of Ala18Arg7Asn,Asp4Cys1Gln4Glu8 Gly1His,Leu4Lys5Met,Ser4Thr4Tyrl, which is in complete agreement with the published amino acid composition. The molecular weight of the unmodified mature protein of 64 amino acid residues was calculated to be 6,950.
Transcription initiation and termination sites. The transcriptional start site of the P. aeruginosa lipoprotein I gene was mapped by primer extension with reverse transcriptase. The primer was the oligodeoxynucleotide It, which is complementary to the sequence between bases 32 and 48 of the lipoprotein I gene (see Fig. 2 ). The template was P. aeruginosa RNA (20 or 40 ,ug) . The product of this reaction was analyzed on a sequencing gel, together with four sequencing reactions of the clone pITaql, with the same primer. The cDNA comigrated with a G in position -62 from the initiator methionine codon (Fig. 3B) , which would correspond to C-62 being the starting nucleotide. There was also a neighboring minor band that migrated with the C in position -61.
The results of the primer extension analysis were checked by an Si protection experiment. A 373-base-pair TaqI-PvuII fragment which was 5'-end labeled with [_y-32P]ATP at the PvuII site was generated from pITaql (see Fig. 1 azine-N,N'-bis(2-ethanesu1fonic acid)]-1 mM EDTA (pH 6.5) . A fragment of 171 ±+ 3 bases was the main protected fragment (Fig. 3A) . The transcriptional start site was calculated at position -59 ± 3 as counted from the initiator methionine. This result agrees well with the primer extension experiment.
With the knowledge of the transcriptional start site, the upstream sequences were searched for a similarity to E. coli promoter consensus sequences. In the -35 region, the sequence TTGGTC is homologous to the E. coli consensus sequence TTGaca; in the -10 region, the sequence TAG TAT is homologous to the E. ccli consensus sequence TAtaaT (30) . Thus The results of 5'-end mapping experiments, together with the prediction of the 3' end, yielded a length of 363 bases for the lipoprotein I mRNA. As a control, a Northern blot of P. aeruginosa RNA was hybridized with the 32P-labeled oligodeoxynucleotide I1, which was also used for the primer extension reaction (Fig. 3C) . Only one signal was obtained, which corresponds to an RNA of 400 + 50 bases. This supports the previous results.
Expression of the P. aeruginosa lipoprotein I in E. coli. The proteins which were expressed in E. coli cells harboring the plasmid pITaql were analyzed for lipoprotein I by polyacrylamide gel electrophoresis and immunoblotting (Fig. 4) . As a negative control, E. coli cells transformed with pUC18, and as a positive control, P. aeruginosa cells were grown. A membrane fraction and a soluble fraction were obtained from each of the three bacterial cultures as described. For the E. coli(pITaql) preparation, the immunoblot shows a strong reaction of the lipoprotein I antibody with a band of the correct size. No signal could be detected in the case of E. coli(pUC18) (control plasmid). Both membrane and soluble fractions contained lipoprotein I. In the case of lipoprotein I expressed in E. coli, a 2.5-fold larger sample of the membrane fraction was loaded; therefore, the larger part of protein I is contained in the soluble fraction. This was different for the preparations form P. aeruginosa cells, where only a very small portion of the membrane fraction was loaded. Therefore the major part of the lipoprotein I was observed in the membrane fraction. The phage lysate from clone XIS (Fig. 4, lanes 1 ) also contained material that reacted with the protein I antibody. The bands of higher molecular weight that reacted with antilipoprotein antibody in preparations from P. aeruginosa and E. coli(pITaql) possibly correspond to multimeric forms of lipoprotein I. (11) , and the lipoproteins of Erwinia amylovora (51), Morganella morganii (22) , Proteus mirabilis (7), and Serratia marcescens (37) . A comparison of each of these sequences with each other and with the P. aeruginosa lipoprotein I sequence with the RELATE program resulted in a table of standard deviation scores which were taken as a measure of homology. There is a central group of the enterobacterial lipoproteins of E. coli, E. amylovora, M. morganii, S. marcescens, and P. mirabilis with standard deviation scores between 10.7 and 24.1. To this group, but not to any of the other lipoproteins, lipoprotein I of P. aeruginosa is loosely associated with standard deviation scores between 2.1 and 7.6 (average 5.7). Figure 5 shows the alignment of the enterobacterial lipoproteins and P. aeruginosa lipoprotein I. DISCUSSION Lipoprotein I (OprI), like porin protein F (OprF), belongs to the group of outer membrane proteins of P. aeruginosa which are immunologically cross-reactive in all the International Antigenic Typing Scheme serotypes (35) . Its counterpart in E. coli, Braun's lipoprotein, has been the object of various studies because of its unusual posttranslational modification (21) and processing by a separate, globomycinsensitive type of prolipoprotein signal peptidase (23) . From amino acid composition analysis (32) and immunological data (19) (32) .
The G+C content of the lipoprotein I gene (59.4%) was similar to the G+C content of the porin F gene (60.1%) and lower than the average G+C content of the P. aeruginosa genome of 67% (38) . This approaches the situation of the pilin genes, which have the lowest G+C content of the known P. aeruginosa genes (48) . In the case of the lipoprotein I gene, the main contribution to the low G+C content seems to be the high incidence of GCT codons for alanine (18 of 23 codons). If all the alanine codons were changed according to the average distribution of alanine codons in the known P. aeruginosa genes (48) , the G+C content would rise to 65.9%. It remains surprising that P. aeruginosa uses such a large number of rare codons in a gene that is highly expressed, whereas the E. coli lipoprotein gene is devoid of a number of rare codons (25) .
The results of the transcriptional mapping experiments of the lipoprotein I gene using primer extension, Si mapping, TERMINATOR, and Northern blot analysis were comparable to the results that were obtained previously for the porin F gene (13) . Both mRNAs are obviously monocistronic. The 5'-untranslated sequences (62 bases for lipoprotein I and 58 bases for porin F) and the 3'-untranslated sequences (46 bases for lipoprotein I and 47 bases for porin F) are similar. The 5' leader sequence of lipoprotein I contains two more ATG codons, which are in the same reading frame and potentially code for short peptides of 10 or 8 amino acid residues. This may, as in the similar case of porin F, enhance transcription initiation of the highly expressed gene, as has been suggested before (34, 41) .
Upstream of the transcriptional start site of the lipoprotein I gene, promoter elements are found which resemble the consensus se, .ences of strong E. coli promoters. element is TTGGTC for the lipoprotein I gene and TTGTCT for the porin F gene (13) , as compared to the E. coli consensus sequence of TTGaca. The -10 element is TAG TAT for the lipoprotein I gene and TAAACT for the porin F gene, as compared to the E. coli consensus TAtaaT. As a consequence of these rather strong similarities, both genes are expressed under the control of the P. aeruginosa promoters in E. coli, which allowed us in the present study to identify the gene by immunoscreening without the use of an expression library. One important difference is that expression of lipoprotein I, even from high-copy plasmids like pUC19, did not lead to any observable toxic effects on E. coli, whereas porin F expression was rather toxic for E. coli (13, 49) .
From the amino acid composition data of the P. aeruginosa lipoprotein I (32) and the sequence of the E. coli lipoprotein (36) , no strong homology between both lipoproteins was expected. On the other hand, as described in Results, the conserved nature of the functionally important sites allowed the identification of the N terminus of the mature protein. Further investigation of the homology between known lipoprotein sequences placed the sequences of different members of the family Enterobacteriaceae in a group of high homology (see Fig. 5 ) and the P. aeruginosa lipoprotein I sequence in a position of significantly lower homology, with mainly the functional sites being conserved. This reflects the larger phylogenetic distance between the Enterobacteriaceae and pseudomonads. Addition of more lipoprotein sequences to the known ones may add some useful information for evolutionary studies.
The most important function of the lipoprotein in E. coli is to link the outer membrane to the peptidoglycan layer, with the N-terminal, lipid-carrying part inserted into the outer membrane and the C terminus bound covalently to the peptidoglycan. Ipp mutants of E. coli can survive, but their outer membrane fails to invaginate normally during cell division, leading to the formation of large blebs. As a consequence, cells are less viable and more sensitive to some antibiotics (16) . Complementation of these strains with plasmids bearing the P. aeruginosa lipoprotein I gene will show to what extent this gene can replace the E. coli lipoprotein gene. For these experiments it is important to provide plasmids that allow sufficient expression of the heterologous gene. The similar organization of the amino acid sequences of both lipoproteins strongly suggests a similar way of modification as well as a similar function.
To investigate the expression of P. aeruginosa lipoprotein I in E. coli more closely, it will be important to test which of the posttranslational modification steps, such as addition of glycerol, acylation of glycerol, cleavage by signal peptidase II, and acylation of the N terminus, are carried out in E. coli. Especially interesting will be the question of how many fatty acid residues are added, since the E. coli lipoprotein contains three residues (21) and the P. aeruginosa lipoprotein I contains only one (32) . The amount of processing will determine the structure of the material which is used for immunization experiments; inversely, the structure of the material obtained might be influenced by changing the level of expression.
The use of recombinant P. aeruginosa lipoprotein I for mouse protection experiments will permit testing of whether this antigen is protective without any contamination of P. aeruginosa lipopolysaccharide. This is currently under investigation, as well as vaccination studies using preparations of recombinant porin F. Since both antigens are crossreactive between the different International Antigenic Typing Scheme serotypes (35) , cross-protectivity of recombinant outer membrane proteins from one strain towards challenge with another strain might be possible.
